TY - JOUR T1 - In vitro Pharmacodynamics of Enrofloxacin Against an Escherichia coli gyrA Mutant AU - Sorucu, Ali AU - Arslan, Erdem AU - Cengiz, Murat JO - Journal of Animal and Veterinary Advances VL - 10 IS - 18 SP - 2384 EP - 2388 PY - 2011 DA - 2001/08/19 SN - 1680-5593 DO - javaa.2011.2384.2388 UR - https://makhillpublications.co/view-article.php?doi=javaa.2011.2384.2388 KW - Turkey KW -Pharmacodynamic of enrofloxacin KW -Escherichia coli KW -C-T mutation KW -microdilution KW -significant AB - The aim of this study was to investigate in vitro the pharmacodynamics of Enrofloxacin (ENR) against an Escherichia coli gyrA mutant (E. coli MT/128). Broth microdilution testing was used to determine the Minimum Inhibitory Concentration (MIC) amd multi-step resistance selection was performed until reaching 1 μg mL•1 MIC. For time-kill experiments, colony counts were determined by plating each diluted sample onto Plate Count Agar and an integrated pharmacokinetic/pharmacodynamics area measure (log ratio area) was applied to all cfu data. A single C-T mutation was found in gyrA at codon 83. Concentration-dependent bacterial killing was observed for E. coli MT/128. Bactericidal activity for this strain was achieved within 4 h at concentrations • 8 times the MIC with no significant regrowth by 24 h. ER -